Table 1: Longitudinal mixed model analysis of the association between structural damage in the sacroiliac joints (sacroiliitis sum score) and disease-related parameters in patients with early axSpA treated with etanercept for up to 6 years
Table 1: Longitudinal mixed model analysis of the association between structural damage in the sacroiliac joints (sacroiliitis sum score) and disease-related parameters in patients with early axSpA treated with etanercept for up to 6 years